Compassionate Use Agreement Sample Contracts
ContractCompassionate Use Agreement • July 31st, 2020
COMPASSIONATE USE – Institution Agreement SPECIFICKÝ LÉČEBNÝ PROGRAM –smlouva s Poskytovatelem zdravotních služeb REGARDING Pre-Approval Access/Compassionate Use of Entrectinib for Patients with Solid Tumors harboring a NTRK Gene Fusion or Patients with Non-Small Cell Lung Cancer (NSCLC) harboring a ROS1 Gene Fusion (AG40852) VE VĚCI Specifický léčebný program přípravkem Entrectinib v léčbě pacientů se solidními tumory s fúzí genu NTRK nebo pacientů s nemalobuněčným plicním karcinomem (NSCLC) s fúzí genu ROS1 (AG40852) THIS AGREEMENT (hereinafter referred to as this “Agreement”) dated below is made by and between the following Parties: TATO SMLOUVA (dále jen „Smlouva“) ze dne uvedeného níže se uzavírá mezi následujícími Stranami: Fakultní nemocnice Plzeň Fakultní nemocnice Plzeň with its registered office at Edvarda Beneše 1128/13, 305 99 Plzeň,Identification number: 00669806, Tax identification number: CZ00669806, represented by MUDr. Václav Šimánek, Ph.D., Director, se sídlem E
Standard Contracts
COMPASSIONATE USE – Treating Physician AgreementCompassionate Use Agreement • September 17th, 2020
Pre-Approval Access/Compassionate Use of Entrectinib for Patients with Solid Tumors harboring a NTRK Gene Fusion or Patients with Non-Small Cell Lung Cancer (NSCLC) harboring a ROS1 Gene Fusion (AG40852)
ContractCompassionate Use Agreement • July 28th, 2020
COMPASSIONATE USE – Institution Agreement SPECIFICKÝ LÉČEBNÝ PROGRAM –smlouva s poskytovatelem zdravotních služeb REGARDING Pre-Approval Access/Compassionate Use of Entrectinib for Patients with Solid Tumors harboring a NTRK Gene Fusion or Patients with Non-Small Cell Lung Cancer (NSCLC) harboring a ROS1 Gene Fusion (AG40852) VE VĚCI Specifický léčebný program přípravkem Entrectinib v léčbě pacientů se solidními tumory s fúzí genu NTRK nebo pacientů s nemalobuněčným plicním karcinomem (NSCLC) s fúzí genu ROS1 (AG40852) THIS AGREEMENT (hereinafter referred to as this “Agreement”) dated below is made by and between the following Parties: TATO SMLOUVA (dále jen „Smlouva“) ze dne uvedeného níže se uzavírá mezi následujícími Stranami: Fakultní nemocnice Hradec KrálovéSokolská 581, 500 05 Hradec Králové - Nový Hradec Králové, ID No. 00179906 Fakultní nemocnice Hradec KrálovéSokolská 581, 500 05 Hradec Králové- Nový Hradec Králové, IČO: 00179906 (hereinafter known as “INSTITUTION”) (dále
AgreementCompassionate Use Agreement • April 3rd, 2020
• That the Undersigned has been infected by COVID-19 (or: is waiting further investigation regarding potential COVID-19 infection);
COMPASSIONATE USE – Treating Physician AgreementCompassionate Use Agreement • August 29th, 2024
Pre-Approval Access/Compassionate Use of glofitamab for treatment of patients with relapsed/refractory Diffuse Large B-Cell Lymphoma (r/r DLBCL), transformed Follicular Lymphoma (tFL) or Primary Mediastinal B-Cell Lymphoma (PMBCL) according to global Compassionate Use Program AG42296
COMPASSIONATE USE – Institution Agreement SPECIFICKÝ LÉČEBNÝ PROGRAM –Compassionate Use Agreement • September 17th, 2020
Pre-Approval Access/Compassionate Use of Entrectinib for Patients with Solid Tumors harboring a NTRK Gene Fusion or Patients with Non-Small Cell Lung Cancer (NSCLC) harboring a ROS1 Gene Fusion (AG40852)